These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15172052)

  • 1. Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in ganglioglioma.
    Law M; Meltzer DE; Wetzel SG; Yang S; Knopp EA; Golfinos J; Johnson G
    Magn Reson Imaging; 2004 Jun; 22(5):599-606. PubMed ID: 15172052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
    Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial ganglioglioma: clinicopathological and MRI findings in 16 patients.
    Zhang D; Henning TD; Zou LG; Hu LB; Wen L; Feng XY; Dai SH; Wang WX; Sun QR; Zhang ZG
    Clin Radiol; 2008 Jan; 63(1):80-91. PubMed ID: 18068794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
    Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
    J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance imaging diagnosis of grades I and II ganglioglioma].
    Liu G; Xu YK
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):310-2. PubMed ID: 19246309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of the use of MR tomography-based cerebral blood volume maps in the diagnosis of brain tumors].
    Hackländer T; Hofer M; Reichenbach J; Bettag JM; Kiwit JC; Herzog H; Mödder U
    Rofo; 1995 Dec; 163(6):484-9. PubMed ID: 8547618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.
    Jenkinson MD; Smith TS; Joyce KA; Fildes D; Broome J; du Plessis DG; Haylock B; Husband DJ; Warnke PC; Walker C
    Neuroradiology; 2006 Oct; 48(10):703-13. PubMed ID: 16937145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma.
    Haris M; Husain N; Singh A; Husain M; Srivastava S; Srivastava C; Behari S; Rathore RK; Saksena S; Gupta RK
    J Comput Assist Tomogr; 2008; 32(6):955-65. PubMed ID: 19204461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management].
    Metellus P; Dutertre G; Mekkaoui C; Nanni I; Fuentes S; Ait-Ameur A; Chinot O; Dufour H; Figarella-Branger D; Cordoliani YS; Grisoli F
    Neurochirurgie; 2008 Aug; 54(4):503-11. PubMed ID: 18573509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
    Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
    J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
    Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
    AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
    Batra A; Tripathi RP; Singh AK
    Australas Radiol; 2004 Sep; 48(3):324-32. PubMed ID: 15344981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
    Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
    J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.